Nature 403, 901906 (2000)
Evidence was reported according to the neuropsychiatric condition under investigation: cognitive disorders (dementia, Parkinsons disease), substance-use disorders, psychotic disorders, mood and anxiety disorders, and eating disorderseach subdivided into pre-clinical and mechanistic evidence, and clinical evidence, the latter reported following a hierarchy of evidence (that is, meta-analyses, clinical trials, observational studies, case series)
This allows for more effective support at the cellular level, addressing deficiencies that contribute to fatigue, poor recovery, and suboptimal internal function
We currently understand its primary actions to be: GLP-1 (Glucagon-Like Peptide-1) Receptor Agonism: This action is known to enhance insulin secretion in a glucose-dependent manner, slow gastric emptying, and significantly suppress appetite by acting on the central nervous system
Your response to tirzepatide depends on numerous individual factors, and understanding these variables helps explain why outcomes vary among patients